Page last updated: 2024-12-08

desmethylcyproheptadine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

desmethylcyproheptadine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159718
SCHEMBL ID2865822
MeSH IDM0113545

Synonyms (25)

Synonym
piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-
desmethylcyproheptadine
14051-46-8
4-(5h-dibenzo[a,d][7]annulen-5-ylidene)piperidine
AKOS007930890
unii-6dr55r4rjp
6dr55r4rjp ,
piperidine,4-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-
4-dibenzo[a,d]cyclohepten-5-ylidene-piperidine
SCHEMBL2865822
4-(5h-dibenzo[a,d]cyclohepten-5-ylidene)piperidine
4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-piperidine
4-(5h-dibenzo[a,d] cyclohepten-5-ylidene)piperidine
4-(5h-dibenzo [a,d]cyclohepten-5-ylidene)piperidine
4-(5-dibenzo[a,d]cycloheptenylidene)piperidine
INPJSDMJYRCDGA-UHFFFAOYSA-N
desmethyl cyproheptadine
DTXSID50161418
piperidine, 4-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-
A901555
n-desmethyl cyproheptadine
norcyproheptadine
n-desmethylcyproheptadine
demethylcyproheptadine
4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"In order to elucidate the interaction between cyproheptadine (CPH) and tipepidine (TP), the disposition of CPH and its metabolites from plasma and the hepatic drug metabolizing enzyme activities in rats dosed singly or repeatedly were investigated."( Drug interaction between cyproheptadine and tipepidine. Effect of single and repeated administrations.
Fujii, Y; Iwaki, M; Ogiso, T; Tanino, T; Yamashita, K, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.14 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]